Comparison results
| Results: Differences General | ✘A71 | ✘B83.1 | ||||||||||
| Related research | Analogs | Analogs | ||||||||||
| ||||||||||||
| Distinctive symptoms | ||||||||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | ||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | ||||||||||
| conjunctivitis | 69% | — | ||||||||||
| nematodes | — | 48% | ||||||||||
| viral conjunctivitis | 66% | — | ||||||||||
| nose itching wandering | — | 47% | ||||||||||
| chronic condition | 64% | — | ||||||||||
| itchy eyelids | — | 34% | ||||||||||
| clamidiosis | 62% | — | ||||||||||
| urine discharge when coughing | — | 34% | ||||||||||
| chlamydial conjunctivitis | 61% | — | ||||||||||
| migrating larva | — | 34% | ||||||||||
| blepharoconjunctivitis | 52% | — | ||||||||||
| stool after the day | — | 32% | ||||||||||
| corneal ulcer | 52% | — | ||||||||||
| meningitis | — | 32% | ||||||||||
| inflammation of the eyes | 51% | — | ||||||||||
| helminths | — | 31% | ||||||||||
| pannus | 45% | — | ||||||||||
| cysts | — | 30% | ||||||||||
| peptic ulcer | 44% | — | ||||||||||
| itching of the extremities | — | 30% | ||||||||||
| keratitis | 43% | — | ||||||||||
| damage to the nervous system | — | 30% | ||||||||||
| conjunctivitis purulent | 43% | — | ||||||||||
| swelling with itching | — | 29% | ||||||||||
| sand in the eyes | 40% | — | ||||||||||
| wandering pains | — | 27% | ||||||||||
| eyes purulent discharge | 39% | — | ||||||||||
| tingling in the extremities | — | 26% | ||||||||||
| red eyelids | 37% | — | ||||||||||
| feeling of heat | — | 26% | ||||||||||
| visual impairment | 37% | — | ||||||||||
| fever cough | — | 26% | ||||||||||
| inflammation of the appendages | 37% | — | ||||||||||
| high temperature | — | 25% | ||||||||||
| nose eye fatigue | 36% | — | ||||||||||
| chest pain when coughing | — | 24% | ||||||||||
| conjunctiva redness | 35% | — | ||||||||||
| swelling of the extremities | — | 24% | ||||||||||
| infectious eye diseases | 35% | — | ||||||||||
| skin problems | — | 24% | ||||||||||
| corneal opacity | 34% | — | ||||||||||
| changes in urine | — | 24% | ||||||||||
| lacrimation | 33% | — | ||||||||||
| hemorrhagic stroke | — | 24% | ||||||||||
| crying during complaints | 33% | — | ||||||||||
| swelling from a bite | — | 23% | ||||||||||
| heavy eyes | 32% | — | ||||||||||
| apoplexy | — | 23% | ||||||||||
| red blood vessels of the eyes | 32% | — | ||||||||||
| limbs pain | — | 23% | ||||||||||
| discharge from the eyes | 31% | — | ||||||||||
| eye surgery | — | 22% | ||||||||||
| weakening of immunity | 28% | — | ||||||||||
| tingling | — | 22% | ||||||||||
| beriberi | 28% | — | ||||||||||
| stroke | — | 21% | ||||||||||
| clear boundaries | 28% | — | ||||||||||
| leukoencephalitis | — | 21% | ||||||||||
| blurred vision | 28% | — | ||||||||||
| cough | — | 20% | ||||||||||
| inflammation | 45% | 16% | ||||||||||
| itchy skin | — | 20% | ||||||||||
| fighting | 26% | — | ||||||||||
| pain chest | — | 20% | ||||||||||
| zpr fatigue from the disease | 26% | — | ||||||||||
| soreness of the skin | — | 19% | ||||||||||
| subacute condition | 25% | — | ||||||||||
| hematuria | — | 19% | ||||||||||
| scarring | 25% | — | ||||||||||
| attacks of pain | — | 18% | ||||||||||
| immunodeficiency | 25% | — | ||||||||||
| necrosis | — | 18% | ||||||||||
| lowered | 21% | — | ||||||||||
| acute pain | — | 18% | ||||||||||
| swelling of eyelids | 37% | 28% | ||||||||||
| swelling | 23% | 18% | ||||||||||
| history of surgery | 20% | 16% | ||||||||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
